➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
McKesson
McKinsey
Medtronic
Express Scripts

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

FENOFIBRIC ACID Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Fenofibric Acid, and what generic alternatives are available?

Fenofibric Acid is a drug marketed by Actavis Elizabeth, Alembic Pharms Ltd, Anchen Pharms, Aurobindo Pharma Ltd, Graviti Pharms, Impax Labs Inc, Lupin Ltd, Mylan Pharms Inc, and Twi Pharms. and is included in nine NDAs.

The generic ingredient in FENOFIBRIC ACID is choline fenofibrate. There are one hundred and two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the choline fenofibrate profile page.

Drug patent expirations by year for FENOFIBRIC ACID
Drug Prices for FENOFIBRIC ACID

See drug prices for FENOFIBRIC ACID

Recent Clinical Trials for FENOFIBRIC ACID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chong Kun Dang PharmaceuticalPhase 1
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all FENOFIBRIC ACID clinical trials

Pharmacology for FENOFIBRIC ACID

US Patents and Regulatory Information for FENOFIBRIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 200920-001 Oct 7, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Twi Pharms FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 210469-002 Jul 5, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 212598-001 Jul 25, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Alembic Pharms Ltd FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 208705-002 May 12, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Impax Labs Inc FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 200264-002 Sep 7, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 212598-002 Jul 25, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Harvard Business School
Dow
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.